Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

r of 2007. Included in R&D spending in the third quarter of 2007 was $20 million related to an upfront payment made for a licensing transaction. The increase in R&D expenses was due to the inclusion of OBS expenses, higher spending for clinical trials and related activities, and investments to build greater breadth and capacity to support Schering-Plough's expanding global R&D pipeline.

Recent Developments

The company also offered the following summary of recent significant developments that have previously been announced, including:

-- Gained European Commission (EC) approval of BRIDION (sugammadex)

injection, the first and only selective relaxant binding agent and the

first major pharmaceutical advance in the field of anesthesia in two

decades. (Announced July 29)

-- Received a "not-approvable" letter from the U.S. Food and Drug

Administration for sugammadex. (Announced August 1)

-- Reported top-line results from a planned interim analysis of a Phase II

study of boceprevir, an investigational oral hepatitis C protease

inhibitor. (Announced August 4)

-- Announced expansion of the company's presence in China and

establishment of Shanghai Schering-Plough Pharmaceutical Co. Ltd., as a

wholly owned operation based in Shanghai through the acquisition of

shares of former joint venture partners. (Announced August 12)

-- Began the European launch of BRIDION injection. (Announced September

10)

-- Closed a transaction with Pfizer Animal Health to divest to Pfizer

certain animal health products from selected franchises in the European

Economic Area as requested by the EC as part of clearing

Schering-Plough's acquisition of OBS. (Announced September 10)

-- Ranked No. 5 in the Top 20 list of Science magazine's annual online

Top Employer Survey. (Reported October 1
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... July 14, 2014 MED-Ed Facilities is ... our next conference, April 7+8 in Boston at the ... at the recent event. Presentations by individuals or teams ... To review the types of sessions that were presented ... Submit your proposal today! , Conference Director, The ...
(Date:7/13/2014)... 2014 MillionaireCasket.com is a professional supplier of ... wood caskets are selling well in the global market. Recently, ... caskets and launched a special offer for all the ... all the company’s cherry caskets are made with superb materials. ... for people to show respect to the departed saint. MillionaireCasket.com ...
(Date:7/13/2014)... York (PRWEB) July 13, 2014 Intraocular ... Trends and Forecast 2013 - 2019 , Intraocular lens ... suffering from myopia or cataracts. The lenses are inserted ... the cataract surgery intraocular lens replaces the focusing power ... with original crystalline lens to deliver the light focusing ...
(Date:7/13/2014)... July 13, 2014 Victorian Hotel has ... promoting the rental of bikes for its "Cycle the ... Victorian Hotel to tour the area using a rental ... Bicycle enthusiasts love to call Vancouver home, as it ... cycle travel and picturesque journeys through the countryside. Vancouver ...
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
Breaking Medicine News(10 mins):Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4
... 18, 2011) Scientists at the Children,s Center for ... of Children,s Hospital Los Angeles today announced a breakthrough ... They have identified a protein called CD19-ligand (CD19-L) located ... facilitates the recognition and destruction of leukemia cells by ...
... 18 (HealthDay News) -- A disease the affects your legs ... About 9 million Americans over the age of 50 ... risk for heart attack, according to the Vascular Disease Foundation ... have the condition, the foundation says. PAD occurs when ...
... Center for World Health & Medicine at Saint Louis University ... forming a global research partnership that initially will focus on ... connected by a shared commitment to fight a devastating disease, ... scientists who formerly worked together in Chesterfield, Mo. GIBH ...
... Wittig, M.D., chief of the division of skin and ... Hackensack University Medical Center will present eleven different educational ... upcoming American Academy of Orthopaedic Surgeons Conference. Dr. Wittig ... practices in limb-sparing surgery. In 2009, he and his ...
... rich plasma (PRP) to promote healing in various surgeries, ... PRP did not improve healing after rotator cuff repair. ... investigators, will be presented at the upcoming American Orthopedic ... held Feb. 19 in San Diego, Calif., following the ...
... Parents and caregivers have traditionally relied on cribs, playpens ... The massive crib recalls followed by the announcement in ... Commission (CPSC) to ban drop-side cribs have caused many ... new study conducted by researchers at the Center for ...
Cached Medicine News:Health News:Scientists bioengineer a protein to fight leukemia 2Health News:Leg Discomfort Might Signal Heart Trouble 2Health News:Saint Louis U scientists partner on malaria research 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 2Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 3Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 4Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 5Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 6Health News:John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques 7Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 2Health News:Study shows PRP, commonly used technique to improve healing, doesn't work in rotator cuff surgery 3Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 2Health News:New study finds 9,500 ED visits related to cribs, playpens and bassinets each year in US 3
(Date:7/10/2014)... Utah , July 10, 2014  BC Technical, ... and MiE America , Inc., a leading provider ... entered into a long-term agreement naming BC Technical as ... US. MiE and BC Technical announced ... agreement to establish BC Technical as the service and ...
(Date:7/10/2014)... Mass. , July 10, 2014  Decision ... of surveyed infectious disease (ID) specialists are willing ... Company,s Orbactiv (oritavancin) for use as OPAT, approximately ... prescribe these agents to their hospital inpatients. However, ... of OPAT patients are initiated on OPAT following ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... Inc. (Nasdaq: ANTH ), today announced financial results ... Financial Results: Total operating ... $18.7 million, as compared to $6.5 million for the same ... quarter of 2011 were driven by expenses related to site ...
... STAAR Surgical Company (NASDAQ: STAA ), ... ophthalmic products, today reported financial results for the first ... increased 8% to $14.8 million over the first quarter ... (IOL and ICL) sales.  The Company achieved its first ...
Cached Medicine Technology:Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 2STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 3STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 4STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 6STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 7STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 8STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 9STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 10STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 11
... The MEL 80 is a top quality ... the correction of vision defects even safer, ... of this ultramodern work platform are oriented ... and the rapid recovery of vision. Key ...
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
... be mounted at the patient's bedside, on ... The design retains many of the proven ... the pump drive motor circuits, flow estimator, ... system. Retaining these subsystems maintains compatibility ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: